Preliminary scientific studies show conolidine might inhibit precise ion channels, reducing neuronal excitability and restricting soreness indicators. This mechanism is especially applicable in neuropathic ache, exactly where abnormal signaling brings about persistent pain. In addition, conolidine appears to impact G protein-coupled receptor (GPCR)